HABS-HD - Core G - Development Core

HABS-HD - 核心 G - 开发核心

基本信息

项目摘要

HABS-HD DEVELOPMENT CORE - ABSTRACT There is a disproportionate burden of Alzheimer’s disease (AD) and AD related disorders (ADRDs) among underrepresented groups (URGs), especially African American and Hispanic populations. This excess AD/ADRD morbidity, and its attendant socioeconomic costs, is expected to get even larger given that older URG adults are a rapidly expanding segment of the U.S. population. Specifically, epidemiological projections indicate that by 2060 the U.S. will become considerably “non-white,” as reflected by a 42% increase in the percentage of African Americans and a 114% increase in the percentage of persons of Hispanic origin, compared to an 8.2% decrease in the proportion of non-Hispanic whites. In light of this reality of an increasingly diverse U.S., it is imperative to curate educational opportunities that foster the training of a diverse workforce to meet the nation’s biomedical, behavioral, clinical and translational needs in AD/ADRDs. Such opportunities would help ensure the availability of a pipeline of ethnoculturally/linguistically diverse and culturally competent professionals prepared to study, evaluate, diagnose, and treat URG older adults with ADRDs. The need for such an initiative, at this point in time, is further underscored by the fact that despite ongoing efforts at the federal level to facilitate the participation of URGs in research careers, underrepresentation remains a persistent problem as evidenced by recent reports from the National Science Foundation and others showing, as an example, that persons from a URG background comprise only 5% of tenure-track neuroscience faculty despite making up a significantly larger slice of the U.S. population. Therefore, the overarching objective of the Development Core of the Health & Aging Brain Study – Health Disparities (HABS-HD) is to recruit, support, and provide targeted mentored training to an annual cohort of URG trainees (graduate/professional students, postdoctoral fellows, and early career investigators, to be known as HABS-HD Fellows) to ensure their research proficiency and cultural competency. We will equip them with the conceptual knowledgebase, practical skillset, and allied resources that will be beneficial for launching successful independent research careers in the AD/ADRD field. Trainees from a non-URG background who have a commitment to health disparities research will also be considered for this mentorship opportunity, as our ultimate goal is to address the current lack of an ethnoculturally/linguistically diverse and culturally competent AD/ADRD workforce. To address our objective, the Development Core will address the following Specific Aims: Aim 1: Deliver a targeted mentored training program to ensure research proficiency and cultural competency. Aim 2. Measure the effectiveness of the HABS-HD mentored training program.
HABS -HD开发核心 - 摘要 阿尔茨海默氏病(AD)和与AD相关疾病(ADRD)的伯恩伯恩(Burnen)不成比例 代表性不足的团体(URG),尤其是非裔美国人和西班牙裔人口。这超出了广告/adrd 鉴于年龄较大的成年人是 美国人口的迅速扩大。具体而言,流行病学项目表明 2060年美国将变得“非白人”,反映出非洲的百分比增加了42% 美国人,西班牙裔人的百分比增加了114%,而下降了8.2% 在非西班牙裔白人的比例中。鉴于美国日益多样化的现实,必须 策划的教育机会,促进对潜水员劳动力的培训,以满足国家的生物医学, AD/ADRD中的行为,临床和翻译需求。这样的机会将有助于确保可用性 一条民族文化/语言多元化和具有文化能力的专业人士的管道,准备学习, 用ADRD评估,诊断和治疗URG老年人。在此时间点需要这样的倡议, 目的地在联邦一级努力促进参与的事实进一步强调了 研究职业的URG,代表性不足仍然是一个持久的问题,最近的报告证明了 例如,来自国家科学基金会和其他人,例如,来自URG背景的人 仅占统治轨道神经科学教师的欲望中只有5%,构成了美国的更大切片 人口。因此,健康与衰老大脑的发展核心的总体目标 研究 - 健康差异(HABS-HD)是招募,支持并提供针对性的修订培训 一年一度的URG学员(研究生/专业学生,博士后研究员和早期职业生涯 调查人员,被称为HABS-HD研究员),以确保他们的研究水平和文化 能力。我们将配备他们的概念知识基础,实用技能和相关资源 这将有助于在广告/ADRD领域开展成功的独立研究职业。学员 从对健康差异研究承诺研究的非ARG背景也将被考虑 这一精明的机会,因为我们的最终目标是解决当前在民族文化上/语言上缺乏的问题 多元化和文化胜任的广告/ADRD劳动力。为了满足我们的目标,发展核心将 解决以下特定目的:目标1:提供针对性的修补培训计划,以确保研究 熟练和文化能力。目标2。衡量HABS-HD Mendored培训的有效性 程序。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OZIOMA C OKONKWO其他文献

OZIOMA C OKONKWO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OZIOMA C OKONKWO', 18)}}的其他基金

KLOTHO and Resilience to Synaptic Dysfunction in Preclinical AD
KLOTHO 和临床前 AD 中突触功能障碍的恢复力
  • 批准号:
    10587987
  • 财政年份:
    2023
  • 资助金额:
    $ 112.06万
  • 项目类别:
Longitudinal Investigation of Cardiorespiratory Fitness and AD Biomarkers in an At-Risk Cohort
高危人群心肺健康和 AD 生物标志物的纵向调查
  • 批准号:
    10064984
  • 财政年份:
    2019
  • 资助金额:
    $ 112.06万
  • 项目类别:
Longitudinal Investigation of Cardiorespiratory Fitness and AD Biomarkers in an At-Risk Cohort
高危人群心肺健康和 AD 生物标志物的纵向调查
  • 批准号:
    10318633
  • 财政年份:
    2019
  • 资助金额:
    $ 112.06万
  • 项目类别:
Longitudinal Investigation of Cardiorespiratory Fitness and AD Biomarkers in an At-Risk Cohort
高危人群心肺健康和 AD 生物标志物的纵向调查
  • 批准号:
    10082736
  • 财政年份:
    2019
  • 资助金额:
    $ 112.06万
  • 项目类别:
Longitudinal Investigation of Cardiorespiratory Fitness and AD Biomarkers in an At-Risk Cohort
高危人群心肺健康和 AD 生物标志物的纵向调查
  • 批准号:
    10535455
  • 财政年份:
    2019
  • 资助金额:
    $ 112.06万
  • 项目类别:
Genetic and Lifestyle Determinants of Cognitive Resilience in Midlife
中年认知弹性的遗传和生活方式决定因素
  • 批准号:
    9014375
  • 财政年份:
    2016
  • 资助金额:
    $ 112.06万
  • 项目类别:
Early detection of asymptomatic middle-age adults at risk for AD
早期发现有 AD 风险的无症状中年人
  • 批准号:
    8723051
  • 财政年份:
    2013
  • 资助金额:
    $ 112.06万
  • 项目类别:
Early detection of asymptomatic middle-age adults at risk for AD
早期发现有 AD 风险的无症状中年人
  • 批准号:
    8867116
  • 财政年份:
    2013
  • 资助金额:
    $ 112.06万
  • 项目类别:
Early detection of asymptomatic middle-age adults at risk for AD
早期发现有 AD 风险的无症状中年人
  • 批准号:
    9328299
  • 财政年份:
    2013
  • 资助金额:
    $ 112.06万
  • 项目类别:
Early detection of asymptomatic middle-age adults at risk for AD
早期发现有 AD 风险的无症状中年人
  • 批准号:
    8593003
  • 财政年份:
    2013
  • 资助金额:
    $ 112.06万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
  • 批准号:
    10748859
  • 财政年份:
    2024
  • 资助金额:
    $ 112.06万
  • 项目类别:
DULCE (Diabetes InqUiry Through a Learning Collaborative Experience)
DULCE(通过学习协作体验进行糖尿病查询)
  • 批准号:
    10558119
  • 财政年份:
    2023
  • 资助金额:
    $ 112.06万
  • 项目类别:
Increasing initiation of evidence-based weight loss treatment
越来越多地开始开展循证减肥治疗
  • 批准号:
    10735201
  • 财政年份:
    2023
  • 资助金额:
    $ 112.06万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 112.06万
  • 项目类别:
Racial Disparities in Alzheimer's Disease and Related Dementias: The Role of School Segregation and Experiences of Discrimination
阿尔茨海默病和相关痴呆症的种族差异:学校隔离的作用和歧视经历
  • 批准号:
    10606362
  • 财政年份:
    2023
  • 资助金额:
    $ 112.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了